LL-37 is the only known member of the cathelicidin family of antimicrobial peptides expressed naturally in humans. It serves as a vital, multi-functional component of the innate immune system.
While it is heavily researched for its therapeutic applications, its main scientific benefits center on its direct pathogen-fighting abilities and tissue-repair mechanics:
Broad-Spectrum Antimicrobial Defense: Destroys Gram-positive and Gram-negative bacteria, fungi, and enveloped viruses by physically disrupting their protective outer cell membranes.
Biofilm Disruption: Breaks down tough, sticky bacterial biofilms that protect colonies from traditional antibiotics, helping to combat drug-resistant strains.
Accelerated Wound Healing: Promotes the migration and growth of keratinocytes (skin cells) and enhances epithelialization to speed up wound closure.
Angiogenesis Support: Stimulates the formation of new blood vessels, ensuring oxygen and vital nutrients reach damaged tissues for proper recovery.
Balanced Immune Modulation: Recruits key defense cells like neutrophils and T-cells to infection zones, while concurrently down-regulating hyper-inflammatory cytokines to prevent immune overreactions.
Anti-Sepsis and Anti-Endotoxin Activity: Binds directly to and neutralizes bacterial lipopolysaccharides (LPS), which minimizes the risk of toxic shock and severe systemic inflammation.